Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

Worried about skyrocketing prescription drug costs? Medicare's new spending cap is bringing welcome relief to seniors, with ...

It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have ...

There are expenses that Medicare won't cover in 2025, and it's important to find other ways to cover these costs.

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

Trump asks the drug industry to voluntarily lower prices for U.S. consumers or be subject to a barrage of regulatory actions to force lower prices.

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...

New government inflation data shows the pace of inflation has subsided from pandemic-era highs. Social Security beneficiaries ...